Pharmacogenomic Testing to Select Antiplatelet Therapy

被引：9
|
作者：
Price, Matthew J. [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Scripps Clin, Div Cardiovasc Dis, 9898 Genesee Ave,AMP 200, La Jolla, CA 92037 USA
[2] Univ Florida, Div Cardiol, Jacksonville, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 17期
关键词：
acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; DOSE CLOPIDOGREL; GENETIC POLYMORPHISMS; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; TICAGRELOR; PRASUGREL; STANDARD; IMPLANTATION;
D O I：
10.1016/j.jacc.2018.03.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1878 / 1881
页数：4
相关论文
共 50 条
  • [1] How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
    Li, Jing
    Yan, Guang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 271 : 28 - 28
  • [2] Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
    De Rosa, Roberta
    Palmerini, Tullio
    Piscione, Federico
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 271 : 30 - 30
  • [3] Antiplatelet therapy: Pharmacogenomic approach to tailor drug therapy
    Lim G.B.
    Nature Reviews Cardiology, 2018, 15 (5) : 256 - 256
  • [4] Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting
    Massmann, Amanda
    Christensen, Kurt D.
    Van Heukelom, Joel
    Schultz, April
    Shaukat, Muhammad Hamza Saad
    Hajek, Catherine
    Weaver, Max
    Green, Robert C.
    Wu, Ann Chen
    Hickingbotham, Madison R.
    Zoltick, Emilie S.
    Stys, Adam
    Stys, Tomasz P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 (08) : 895 - 902
  • [5] Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients
    Black, Rachel M.
    Williams, Alexis K.
    Ratner, Lindsay
    Crona, Daniel J.
    Wiltshire, Tim
    Weck, Karen E.
    Stouffer, George A.
    Lee, Craig R.
    PHARMACOGENOMICS, 2020, 21 (07) : 431 - 441
  • [6] Testing antiplatelet therapy
    Gachet, Christian
    Aleil, Boris
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0A) : A28 - A34
  • [7] Integration of Pharmacometabolomic and Pharmacogenomic Approaches Reveals Novel Insights Into Antiplatelet Therapy
    Lewis, J. P.
    Yerges-Armstrong, L. M.
    Ellero-Simatos, S.
    Georgiades, A.
    Kaddurah-Daouk, R.
    Hankemeier, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (05) : 570 - 573
  • [8] Pharmacogenomic Testing and Antithrombotic Therapy: Ready for Prime Time?
    Holmes, David R., Jr.
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2013, 4 (01):
  • [9] Antiplatelet therapy and platelet function testing
    Braunwald, Eugene
    Angiolillo, Dominick
    Bates, Eric
    Berger, Peter B.
    Bhatt, Deepak
    Cannon, Christopher P.
    Furman, Mark I.
    Gurbel, Paul
    Micheson, Alan D.
    Peterson, Eric
    Wiviott, Stephen
    CLINICAL CARDIOLOGY, 2008, 31 (03) : I1 - I1
  • [10] Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
    Notarangelo, Francesca Maria
    Maglietta, Giuseppe
    Bevilacqua, Paola
    Cereda, Marco
    Merlini, Piera Angelica
    Villani, Giovanni Quinto
    Moruzzi, Paolo
    Patrizi, Giampiero
    Tagliazucchi, Guidantonio Malagolia
    Crocamo, Antonio
    Guidorossi, Angela
    Pigazzani, Filippo
    Nicosia, Elisa
    Paoli, Giorgia
    Bianchessi, Marco
    Comelli, Mario Angelo
    Caminiti, Caterina
    Ardissino, Diego
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (17) : 1869 - 1877
12345